Spots Global Cancer Trial Database for hepatic cancer
Every month we try and update this database with for hepatic cancer cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Liver Resection for Patients With Hepatocellular Carcinoma and Impaired Liver Function | NCT06245785 | Hepatic Cancer | transarterial c... | 18 Years - | Tang-Du Hospital | |
| Endoscopic Ultrasound Guided Liver Biopsy | NCT03307811 | Hepatic Cancer Hepatic Neoplas... Hepatic Carcino... | 22 gauge needle... | 19 Years - | AdventHealth | |
| Liver Transplantation With Two-stage Liver Resection in Unresectable Liver Cancer , Metastases or Emd-stage Liver Disease (LTLR-LC) | NCT05750329 | Liver Transplan... Hepatic Cancer End-stage Liver... | assisted liver ... | 18 Years - 75 Years | RenJi Hospital | |
| Safety and Pharmacokinetics of SM04755 in Subjects With Advanced Colorectal, Gastric, Hepatic, or Pancreatic Cancer | NCT02191761 | Colorectal Canc... Gastric Cancer Hepatic Cancer Pancreatic Canc... | SM04755 | 18 Years - | Biosplice Therapeutics, Inc. | |
| RCT of Mobile Apps & FitBit v. Usual Care | NCT03623464 | Pancreatic Canc... Gastric Cancer Hepatic Cancer Colon Cancer Rectal Cancer Small Bowel Can... | Mobile health a... Standard of car... | 18 Years - | Weill Medical College of Cornell University | |
| The Natural History of Solid Organ Cancer Stem Cells (SOCSC) | NCT00923052 | Hepatic Cancer Pancreatic Duct... Colorectal Canc... Breast Cancer Gastric Cancer | 16 Years - 100 Years | National Institutes of Health Clinical Center (CC) | ||
| Goal-directed vs Preemptive Tranexamic Acid Administration in Non-cardiac Surgery | NCT05957822 | Arthritis Knee Spine Fusion Prostate Cancer Arthritis of Hi... Hepatic Cancer | TXA TEG6 | 19 Years - | Konkuk University Medical Center | |
| GIDEON Non-Nexavar Arm - HCC Patients Who Are Treated With Any Therapy Other Than Nexavar at Individual Study Start | NCT01191385 | Carcinoma, Hepa... | Any treatment f... | 18 Years - | Bayer | |
| A Study of CDX-585 in Patients With Advanced Malignancies | NCT05788484 | Non-small Cell ... Gastric Cancer Head and Neck C... Ovarian Cancer Primary Periton... Fallopian Tube ... Bladder Urothel... Colorectal Canc... Esophageal Canc... Hepatic Cancer Renal Cell Carc... Cholangiocarcin... Pancreatic Canc... Other Solid Tum... | CDX-585 | 18 Years - | Celldex Therapeutics | |
| Goal-directed vs Preemptive Tranexamic Acid Administration in Non-cardiac Surgery | NCT05957822 | Arthritis Knee Spine Fusion Prostate Cancer Arthritis of Hi... Hepatic Cancer | TXA TEG6 | 19 Years - | Konkuk University Medical Center | |
| A Study of the PD-L1xCD27 Bispecific Antibody CDX-527 in Patients With Advanced Malignancies | NCT04440943 | Non-small Cell ... Breast Cancer Gastric Cancer Renal Cell Carc... Ovarian Cancer Primary Periton... Fallopian Tube ... Cholangiocarcin... Bladder Urothel... MSI-H Colorecta... Esophageal Canc... Hepatic Cancer Head and Neck C... Other Solid Tum... | CDX-527 | 18 Years - | Celldex Therapeutics | |
| Immunization With AFP + GM CSF Plasmid Prime and AFP Adenoviral Vector Boost in Patients With Hepatocellular Carcinoma | NCT00669136 | Hepatocellular ... Hepatoma Liver Cancer, A... Liver Cell Carc... Liver Cell Carc... Cancer of Liver Cancer of the L... Cancer, Hepatoc... Hepatic Cancer Hepatic Neoplas... Hepatocellular ... Liver Cancer Neoplasms, Hepa... Neoplasms, Live... | AFP + GM-CSF Pl... | 18 Years - 80 Years | University of Pittsburgh | |
| Bleeding in Laparoscopic Liver Surgery | NCT04609410 | Neuromuscular B... Intraoperative ... Hepatic Cancer | Neuromuscular b... | 18 Years - | Università Vita-Salute San Raffaele | |
| A Study of CDX-1140 (CD40) as Monotherapy or in Combination in Patients With Advanced Malignancies | NCT03329950 | Melanoma Non-small Cell ... Breast Cancer Gastric Cancer Renal Cell Carc... Ovarian Cancer Cholangiocarcin... Bladder Urothel... Pancreatic Aden... Colorectal Canc... Esophageal Canc... Hepatic Cancer Head and Neck C... Primary Periton... Fallopian Tube ... Other Solid Tum... Diffuse Large B... Mantle Cell Lym... Indolent B-cell... Non-Hodgkin Lym... Follicular Lymp... Lymphoplasmacyt... Waldenstrom's D... Marginal Zone L... Mucosa Associat... Small Lymphocyt... | CDX-1140 CDX-301 pembrolizumab Chemotherapy | 18 Years - | Celldex Therapeutics | |
| LC Bead LUMI Radio-Opaque Embolic Beads to Detect and Characterize the Vascularity of Hepatic Tumors During Treatment With Transarterial Embolization (TAE) Alone or Combined With Thermal Ablation | NCT02649868 | Hepatic Cancer Liver Neoplasms Hepatocellular ... Liver Cancer | TAE RFA LC Bead LUMI | 18 Years - 100 Years | National Institutes of Health Clinical Center (CC) | |
| Quality of Life of Patients Over 75 Yars Undergoing Palliative Chemotherapy | NCT04517448 | Colorectal Canc... Pancreatic Canc... Biliary Cancer Hepatic Cancer Oesophageal Can... Gastric Cancer | 75 Years - | Centre Hospitalier de la côte Basque | ||
| Prevention and Treatment of Complications of Endovascular Methods in Patients With Malignant Liver Tumors | NCT04764409 | Hepatic Cancer Metastatic Canc... Chemotherapy Ef... | Chemoembolizati... Chemoinfusion | 18 Years - | Central Clinical Hospital RZD-Medicine, Russian Federation | |
| Immunization With AFP + GM CSF Plasmid Prime and AFP Adenoviral Vector Boost in Patients With Hepatocellular Carcinoma | NCT00669136 | Hepatocellular ... Hepatoma Liver Cancer, A... Liver Cell Carc... Liver Cell Carc... Cancer of Liver Cancer of the L... Cancer, Hepatoc... Hepatic Cancer Hepatic Neoplas... Hepatocellular ... Liver Cancer Neoplasms, Hepa... Neoplasms, Live... | AFP + GM-CSF Pl... | 18 Years - 80 Years | University of Pittsburgh | |
| A Phase II Study of Continuous Hepatic Arterial Infusion With Floxuridine (FUDR) and Dexamethasone (DEX) in Patients With Unresectable Primary Hepatic Malignancy | NCT00587067 | Hepatic Cancer | FLOXURIDINE | 18 Years - | Memorial Sloan Kettering Cancer Center | |
| Phase 1 Study to Evaluate the Safety, Pharmacokinetics and Pharmacodynamics of H3B-6527 in Participants With Advanced Hepatocellular Carcinoma | NCT02834780 | Advanced Hepato... Hepatocellular ... Liver Cancer Liver Neoplasms Hepatic Cancer Hepatic Carcino... | H3B-6527 | 18 Years - | Eisai Inc. | |
| A Study of the PD-L1xCD27 Bispecific Antibody CDX-527 in Patients With Advanced Malignancies | NCT04440943 | Non-small Cell ... Breast Cancer Gastric Cancer Renal Cell Carc... Ovarian Cancer Primary Periton... Fallopian Tube ... Cholangiocarcin... Bladder Urothel... MSI-H Colorecta... Esophageal Canc... Hepatic Cancer Head and Neck C... Other Solid Tum... | CDX-527 | 18 Years - | Celldex Therapeutics | |
| A Study of CDX-1140 (CD40) as Monotherapy or in Combination in Patients With Advanced Malignancies | NCT03329950 | Melanoma Non-small Cell ... Breast Cancer Gastric Cancer Renal Cell Carc... Ovarian Cancer Cholangiocarcin... Bladder Urothel... Pancreatic Aden... Colorectal Canc... Esophageal Canc... Hepatic Cancer Head and Neck C... Primary Periton... Fallopian Tube ... Other Solid Tum... Diffuse Large B... Mantle Cell Lym... Indolent B-cell... Non-Hodgkin Lym... Follicular Lymp... Lymphoplasmacyt... Waldenstrom's D... Marginal Zone L... Mucosa Associat... Small Lymphocyt... | CDX-1140 CDX-301 pembrolizumab Chemotherapy | 18 Years - | Celldex Therapeutics | |
| Direct Peritoneal Resuscitation Plus Conventional Resuscitation | NCT01882218 | Hepatic Cancer | Galactose Standard Treatm... | 18 Years - 75 Years | University of Louisville | |
| Safety and Pharmacokinetics of Treating Liver Cancer With Drug-Eluting Beads | NCT01336985 | Neoplasm Metast... Melanoma Colorectal Neop... | Irinotecan Chemoembolizati... Drug-Eluting Be... Biopsy | 18 Years - 84 Years | National Institutes of Health Clinical Center (CC) | |
| Recombinant Human Thrombopoietin in Children Receiving Ifosfamide, Carboplatin, and Etoposide Chemotherapy | NCT00187109 | Germ Cell Tumor... Hepatic Cancer Neuroblastoma Osteosarcoma Rhabdomyosarcom... | Recombinant Hum... | - 21 Years | St. Jude Children's Research Hospital | |
| A Phase II Study of ABC294640 as Monotherapy in Patients With Advanced Hepatocellular Carcinoma | NCT02939807 | Carcinoma, Hepa... | ABC294640 | 18 Years - | Medical University of South Carolina | |
| Safety and Pharmacokinetics of SM04755 in Subjects With Advanced Colorectal, Gastric, Hepatic, or Pancreatic Cancer | NCT02191761 | Colorectal Canc... Gastric Cancer Hepatic Cancer Pancreatic Canc... | SM04755 | 18 Years - | Biosplice Therapeutics, Inc. | |
| Liver Transplantation With Two-stage Liver Resection in Unresectable Liver Cancer , Metastases or Emd-stage Liver Disease (LTLR-LC) | NCT05750329 | Liver Transplan... Hepatic Cancer End-stage Liver... | assisted liver ... | 18 Years - 75 Years | RenJi Hospital | |
| A Study of CDX-585 in Patients With Advanced Malignancies | NCT05788484 | Non-small Cell ... Gastric Cancer Head and Neck C... Ovarian Cancer Primary Periton... Fallopian Tube ... Bladder Urothel... Colorectal Canc... Esophageal Canc... Hepatic Cancer Renal Cell Carc... Cholangiocarcin... Pancreatic Canc... Other Solid Tum... | CDX-585 | 18 Years - | Celldex Therapeutics | |
| Bleeding in Laparoscopic Liver Surgery | NCT04609410 | Neuromuscular B... Intraoperative ... Hepatic Cancer | Neuromuscular b... | 18 Years - | Università Vita-Salute San Raffaele | |
| Safety Study of Increasing Doses of Combretasatin A1 Diphosphate (OXi4503) as Monotherapy in Subjects With Hepatic Tumor Burden | NCT00960557 | Neoplasm Metast... | Combretastatin ... | 18 Years - | Mateon Therapeutics | |
| Phase 1 Study to Evaluate the Safety, Pharmacokinetics and Pharmacodynamics of H3B-6527 in Participants With Advanced Hepatocellular Carcinoma | NCT02834780 | Advanced Hepato... Hepatocellular ... Liver Cancer Liver Neoplasms Hepatic Cancer Hepatic Carcino... | H3B-6527 | 18 Years - | Eisai Inc. | |
| Safety & Efficacy of NV1020 in Colorectal Cancer Metastatic to the Liver | NCT00149396 | Colorectal Canc... Liver Neoplasms | NV1020 | 18 Years - | MediGene | |
| Direct Peritoneal Resuscitation Plus Conventional Resuscitation | NCT01882218 | Hepatic Cancer | Galactose Standard Treatm... | 18 Years - 75 Years | University of Louisville | |
| Safety & Efficacy of NV1020 in Colorectal Cancer Metastatic to the Liver | NCT00149396 | Colorectal Canc... Liver Neoplasms | NV1020 | 18 Years - | MediGene | |
| A Phase II Study of Continuous Hepatic Arterial Infusion With Floxuridine (FUDR) and Dexamethasone (DEX) in Patients With Unresectable Primary Hepatic Malignancy | NCT00587067 | Hepatic Cancer | FLOXURIDINE | 18 Years - | Memorial Sloan Kettering Cancer Center | |
| A Phase II Study of Continuous Hepatic Arterial Infusion With Floxuridine (FUDR) and Dexamethasone (DEX) in Patients With Unresectable Primary Hepatic Malignancy | NCT00587067 | Hepatic Cancer | FLOXURIDINE | 18 Years - | Memorial Sloan Kettering Cancer Center |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
